Contributions of T cells in multiple sclerosis: what do we currently know?

J Neurol. 2021 Dec;268(12):4587-4593. doi: 10.1007/s00415-020-10275-x. Epub 2020 Oct 20.

Abstract

Background: Multiple sclerosis (MS) is a complex autoimmune disorder characterized by neurologic dysfunction. The symptoms worsen as the disease progresses to the relapsing stage.

Aim: This study aimed to examine the role of T cells in MS pathogenesis.

Materials and methods: The review was performed based on articles obtained from PsycINFO, PubMed, Web of Science, and CINAHL. Search terms and phrases, such as "multiple sclerosis," "MS," "T cells," "development," "Dysregulated T cells," and "Effector T cells", were used to identify articles that could help explore the research topic.

Results: The pathogenesis of MS is linked to the regulatory, inflammatory, suppressive, and effector roles of T cells. However, the actual roles of specific T cell subsets in MS development are not well understood.

Discussion: The study revealed a significant link between MS and T cell activity. Targeting T cells is a potential strategy for the development of new therapies to manage MS.

Conclusion: MS is a complex demyelinating condition that affects several million people around the world. Research has revealed that various classes of T cells, including effector T cells and regulatory T cells, influence the development and progression of MS. Further investigations are required to elucidate the underlying mechanisms through which specific T cell populations influence MS pathogenesis.

Keywords: Effector T-cells; Multiple sclerosis; T-Cells; T-Lymphocytes.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases*
  • Humans
  • Multiple Sclerosis*
  • T-Lymphocytes, Regulatory